← Back

Wire · opportunities

Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral ...

Published

13 August 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at prnewswire.com

Verified

Fusion42 · 13 August 2026 · Fusion42 review

Vesalio has received FDA 510(k) clearance for its pVasc NET, a next-generation peripheral mechanical thrombectomy device featuring an integrated distal filter.

This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

You can now compete in the US market with a cleared peripheral thrombectomy device that reduces embolic risks. This opens immediate US commercial opportunities but also demands rapid compliance with FDA post-clearance standards.

Related on Wire

Topics

Medtechfda-clearancemechanical-thrombectomymedtechmedical-deviceperipheral-vascular